CF PHARMTECH (02652) spent HK$144,000 to repurchase 6,500 shares on May 5th.
Chang Feng Pharmaceuticals (02652) announced that on May 5, 2026, it will spend 144,400 Hong Kong dollars to repurchase 6,500 shares.
CF PHARMTECH (02652) announced on May 5, 2026 that it will spend HKD 144,000 to repurchase 6500 shares.
Related Articles
MS Group Holdings (01451) received an appointment from Director Zhong Guoqiang to transfer approximately 34.96% of the entire purchase offer. Trading will resume on May 6th.
LIANLIAN (02598) spent HKD 497,800 on May 5 to repurchase 83,500 shares.
XTALPI (02228) subsidiary purchased several Shanghai Pudong Development Bank structured deposits totaling 3.561 billion yuan.
MS Group Holdings (01451) received an appointment from Director Zhong Guoqiang to transfer approximately 34.96% of the entire purchase offer. Trading will resume on May 6th.
LIANLIAN (02598) spent HKD 497,800 on May 5 to repurchase 83,500 shares.
XTALPI (02228) subsidiary purchased several Shanghai Pudong Development Bank structured deposits totaling 3.561 billion yuan.
